+ All Categories
Home > Documents > Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke...

Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke...

Date post: 13-Oct-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
32
Acute Ischemic Stroke: Time vs Tissue Greg Albers, MD Coyote Foundation Professor of Neurology and Neurological Sciences Stanford University School of Medicine Director, Stanford Stroke Center Stanford University Medical Center
Transcript
Page 1: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Acute Ischemic Stroke: Time vs Tissue

Greg Albers, MDCoyote Foundation Professor of Neurology and Neurological Sciences

Stanford University School of MedicineDirector, Stanford Stroke Center

Stanford University Medical Center

Page 2: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Stroke Treatment in 2010

Problem: very few stroke patients receive treatment (5%)

Two treatments FDA approved:Intravenous tPA – treatment must begin <3-4.5 hrsMechanical devices; FDA approval but not clear who benefits and effective time window

Page 3: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Advances in Stroke Imaging:Expanding the window for stroke therapy

Page 4: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

The Mismatch Concept

Core(dead)

Penumbra(salvageable)

• Infarct Core (game over):

Diffusion Weighted MRI (DWI)

• Penumbra or salvageable:

Perfusion Weighted MRI (PWI)

• Mismatch ratio:

Penumbra/Core

Page 5: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

The Mismatch Concept

Penumbra(salvageable)

Core(dead)

Page 6: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

DEFUSE Study

DWI / PWIEvaluation For Understanding Stroke Evolution

Page 7: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

6 hrsStroke score

16

PWI: 95 cc ↓ FlowDWI: 3 cc

4.5 hoursafter t–PA

Stroke score 5

6 cc Improved0 cc

Benefit of t-PA At 6 hrs in Mismatch Patients

Page 8: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

215 cc vessel occlusion105 cc

Beforet–PA

> 100 cc vessel open 77 cc

4 hoursafter t–PA

The Malignant Mismatch – t-PA Harmful

Page 9: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Image Analysis

MR tech pushes DWI & PWI to

RAPID

Auto-send

Stroke MRI or CT 00:00Completion of scan

04:30RAPID image analysis complete

05:00Images on PACS

Automated Image Processing Required: RAPID Software

00:30image arrival

Page 10: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

DEFUSE 2 Protocol

MRIbaseline

Intra-arterial Therapy

MRIPost-procedure

(reperfusion)

MRIDay 5

(infarct volume)

Favorable clinical response:•NIHSS score of 0-1 at day 30 orimprovement of NIHSS score by ≥8 points between baseline and day 30

Page 11: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

88-Year-Old Female - IV t-PA Not Effective

Page 12: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

After mechanical clot removal

Complete neurologic recovery at 24 hrs

After Mechanical Clot Removal

Page 13: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Use of Imaging to Monitor Stroke Therapies

Page 14: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

79 yo female, left side paralysis

CT Perfusion at 6.5 hours

Page 15: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Blocked Artery Open at 8 Hours

Angiogram pre and post mechanical device

No blood flow to parts of brain Restored blood flow

Clot

Page 16: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Blocked Artery Open at 8 Hours

Angiogram pre and post mechanical device

No blood flow to parts of brain Restored blood flow

Clot

Page 17: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

DWI at 16 hours

Page 18: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

DWI at 16 hours

Tmax at 16 hours

Page 19: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

DWI at 3 days

DWI at 16 hours

Page 20: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

88-Year-Old Female - IV t-PA Not Effective

Page 21: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Mean MTT 8 Mean XE-CT CBF 15Mean Tmax 4s

61-Yr-Old, 7 hrs After Left Side Paralysis

Page 22: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Recanalization at 6 hours after onset

Page 23: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Baseline PWI lesion=153 cc

Early follow-up PWI lesion=45 cc

Final stroke size= 45 cc

Page 24: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Tissue vs. Time

Page 25: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

62 yo male 2.5 hrs after symptom onset- CT PERFUSION

Page 26: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment
Page 27: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Mean MTT 8 Mean XE-CT CBF 15 Mean Tmax 4s

82 yo female, iv tpa not effective, severe stroke symptoms

Page 28: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Carotid artery open at 4 hours

Page 29: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Mean MTT 8 Mean XE-CT CBF 15 Mean Tmax 4s

Follow-up MRI 4 hours later (8 after onset). Full recovery

Page 30: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

Baseline DWI lesion= 10 cc; NIH 22

Day 3: 5 cc

Baseline PWI lesion

Day 3: Flair lesion = 11 cc; NIH 0

Page 31: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

How to Increase theEffectiveness of Stroke Treatment:

• Use advanced imaging to triage and monitor therapy

• Don’t treat patients with severe irreversible damage

• Treat patients with salvageable tissue even if they arrive late

• Use intravenous tPA for small clots; mechanical devices for large clots

Page 32: Acute Ischemic Stroke: Time vs Tissue · Stroke Treatment in 2010 yProblem: very few stroke patients receive treatment (5%) yTwo treatments FDA approved: Intravenous tPA – treatment

DEFUSE 2 Coordinating Center

R. Bammer

M. MoseleyM. Mlynash

M. Marks

S. Kemp

J.M. Olivot

M. Straka

A. Purushotham

M. Lansberg


Recommended